A diverse array of medical device technologies top the list when it came to getting attention from venture capitalists during the third quarter.
Cutting edge wearables, an implantable stimulation device to treat hypertension, and genetic testing for cancer risk—those are but some of the wide array of medical technologies garnering the largest venture capital raises during the third quarter of 2016, according the MoneyTree Report from by PricewaterhouseCoopers, based on data from Thomson Reuters.
Overall, the medical device industry continues to increase deal numbers and size each quarter this year. Medtech companies raised nearly $663 million during the third quarter, up a fifth from the roughly $550 million raised during the second quarter. There were a total 69 deals, up from 64 the previous quarter.
This year, however, is still lagging behind 2015. For the first nine months of 2016, there were 192 venture capital deals worth a total $1.7 billion in the medical device industry, down from 247 deals worth $2.2 billion during the first nine months of 2015.
Still, there was much cheer for the 10 medtech companies bringing in the most venture capital during the third quarter. Read on to find out more about them.
|Discover more innovative medical device companies at BIOMEDevice San Jose, December 7–8, 2016|
Like what you're reading? Subscribe to our daily e-newsletter.
[image courtesy of IDEA GO/FREEDIGITALPHOTOS.NET]